Relay Therapeutics
RLAY
RLAY
125 hedge funds and large institutions have $3.26B invested in Relay Therapeutics in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 62 increasing their positions, 22 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
Holders
125
Holding in Top 10
8
Calls
$36K
Puts
–
Top Buyers
| 1 | +$166M | |
| 2 | +$38.7M | |
| 3 | +$27.1M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$26M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$20.6M |
Top Sellers
| 1 | -$57.9M | |
| 2 | -$43.4M | |
| 3 | -$34.6M | |
| 4 |
Goldman Sachs
New York
|
-$28.2M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$24.3M |